Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,985	2,527	3,394	3,271	3,794	3,857
Market Cap Growth	8.20%	-25.55%	3.77%	-13.80%	-1.64%	25.69%
Enterprise Value	3,012	2,635	3,600	3,489	3,857	3,958
Last Close Price	9.12	7.51	9.80	9.31	10.60	10.63
PE Ratio	14.04	12.59	20.84	20.24	22.22	23.36
PS Ratio	4.00	3.54	5.05	4.99	5.47	5.09
PB Ratio	2.29	2.00	2.84	3.00	3.80	4.35
P/TBV Ratio	2.42	2.11	3.02	3.21	4.15	4.83
P/FCF Ratio	13.82	17.33	27.39	-	404.58	113.02
P/OCF Ratio	11.79	12.28	17.43	19.71	26.44	21.70
EV/Sales Ratio	4.03	3.69	5.36	5.33	5.56	5.22
EV/EBITDA Ratio	12.65	12.09	18.18	19.73	18.50	18.63
EV/EBIT Ratio	21.74	21.35	29.83	30.25	25.08	24.05
EV/FCF Ratio	13.95	18.07	29.05	-	411.29	115.96
Debt / Equity Ratio	0.15	0.18	0.37	0.39	0.15	0.14
Debt / EBITDA Ratio	0.81	1.06	2.23	2.40	0.71	0.57
Debt / FCF Ratio	0.90	1.58	3.58	-	15.84	3.54
Asset Turnover	0.42	0.40	0.37	0.43	0.55	0.69
Inventory Turnover	1.86	1.81	2.18	1.91	1.77	1.90
Quick Ratio	1.00	0.87	1.14	1.18	0.66	0.67
Current Ratio	1.57	1.35	1.51	1.69	1.17	1.24
Return on Equity (ROE)	16.97%	16.31%	14.17%	15.43%	18.17%	19.93%
Return on Assets (ROA)	4.90%	4.26%	4.18%	4.74%	7.60%	9.41%
Return on Capital (ROIC)	5.52%	4.92%	4.78%	5.41%	8.92%	11.51%
Return on Capital Employed (ROCE)	9.60%	8.60%	7.80%	7.90%	14.30%	16.80%
Earnings Yield	7.16%	7.94%	4.80%	4.94%	4.50%	4.28%
FCF Yield	7.23%	5.77%	3.65%	-2.66%	0.25%	0.89%
Dividend Yield	2.74%	3.33%	2.04%	1.92%	1.68%	1.68%
Payout Ratio	38.48%	38.21%	45.40%	42.57%	36.81%	31.72%
Buyback Yield / Dilution	-1.35%	-0.99%	1.20%	-0.67%	-0.59%	0.09%
Total Shareholder Return	1.39%	2.34%	3.24%	1.25%	1.10%	1.77%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.